Clinical Trials Logo

Filter by:
NCT ID: NCT03310073 Completed - Healthy Clinical Trials

Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV

Start date: July 2016
Phase: Phase 4
Study type: Interventional

This study is to assess protectivity following four doses of bOPV which given simultaneously with Pentabio® and 1 dose of IPV at the 4th visit

NCT ID: NCT03292744 Recruiting - Clinical trials for Frail Elderly Syndrome

Effect of Alfacalcidol to Respiratory Infection and Immune Response of Indonesian Elderly

Start date: January 10, 2017
Phase: Phase 4
Study type: Interventional

Vitamin D has been known to influence immune response through Vitamin D Receptor in Immune Cells, but only few has been known about the effect alfacalcidol, a vitamin D analog to immune system. In elderly, immune disregulation or immunosenecence have great impact to infection response. This study is aimed to determine the effect of alfacalcidol supplementation in vitro and in vivo to respiratory infection incidence and inflammatory markers, as well as T cell lymphocyte subset in Indonesian elderly patients.

NCT ID: NCT03279900 Not yet recruiting - Acute Leukemia Clinical Trials

Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy

Start date: September 2017
Phase: N/A
Study type: Observational

This study use an observational study design from patient medical records to obtain data on patient demographics, nutritional status, 6MP dosing, and albumin levels of LLA child patients.

NCT ID: NCT03273387 Recruiting - Clinical trials for Precapillary Pulmonary Hypertension

The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension in National Cardiovascular Center Harapan Kita Hospital

Start date: June 1, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

Right ventricular dysfunction is the worst mortality predictor in pulmonary arterial hypertension (PAH). Recent study has described that approximately 25% of PAH patients will developed into right ventricular failure despite therapeutic reduction of pulmonary vascular resistance. Subsequently, several studies have shown that fatty acid accumulation in right ventricle was inversely correlated with right ventricular function in PAH patients. Several PAH animal studies have revealed that metabolic glucose oxidation impairment through increased aerobic glycolysis, mitochondrial dysfunction, and lipotoxicity play significant role in right ventricular failure. Moreover, several pulmonary hypertension animal studies have demonstrated the benefit of partial fatty acid inhibitor such as trimetazidine on right ventricle function. It was hypothesize that trimetazidine improved right ventricular function through indirect effect of increased glucose oxidation by blocking the Randle cycle. Therefore, we hypothesize that trimetazidine can improve right ventricular function in pulmonary arterial hypertension patients.

NCT ID: NCT03269929 Completed - Cancer Clinical Trials

Comparison Between Efficacy of Music Therapy and Intravenous Midazolam 0.02 mg/kgBW in Reducing Preoperative Anxiety

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

This study aimed to compare the efficacy of music therapy and midazolam 0,02 mg/kgBW in reducing preoperative anxiety on patients undergoing brachytherapy with spinal anesthesia

NCT ID: NCT03259269 Recruiting - Clinical trials for Tuberculosis, Multidrug-Resistant

Expand New Drugs for TB [endTB]

Start date: February 9, 2016
Phase: N/A
Study type: Observational

This observational study will examine the safety and efficacy of bedaquiline and delamanid used (individually, not together) in routine, multidrug regimens for treatment of MDR-TB. The information gathered in this study will inform doctors how best to use these TB drugs in the future.

NCT ID: NCT03255668 Recruiting - Clinical trials for Leukemia, Lymphoblastic

Hematotoxicity in Maintenance Therapy of Children With Acute Lymphoblastic Leukemia

Start date: July 25, 2017
Phase: N/A
Study type: Observational [Patient Registry]

Subjects who are recruited in this study are LLA patient, who are treated for routine control to Cipto Mangunkusumo Hospital, who meet the inclusion criteria and do not meet the exclusion criteria.

NCT ID: NCT03219398 Recruiting - Healthy Clinical Trials

The Effect of Lower Intraabdominal Pressure on Syndecan-1, sVEGF-R2, Occludin and KIM-1 on Living Donor Laparoscopic Nephrectomy

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

This study aimed to evaluate the increase of intraabdominal pressure 12- 14 mmHg caused by pneumoperitoneum resulted from carbon dioxide (CO2) insufflation induce glycocalyx endothelial injury that cause kidney tubular injury on live donor patient that undergo laparoscopic nephrectomy surgery, and decreasing the intraabdominal pressure to 8-10 mmHg during surgery is expected to reduce the injury.

NCT ID: NCT03214653 Recruiting - Clinical trials for Renal Transplant Recipient Patients

Comparison Between Target-controlled Infusion of Propofol and Sevoflurane as Maintenance of Anesthesia to Hemodynamic Profile of Renal Transplant Recipient

Start date: July 1, 2017
Phase: N/A
Study type: Interventional

This study aimed to compare the effect of target-controlled infusion of propofol and sevoflurane as maintenance of anesthesia to intraoperative hemodynamic profile of renal transplant recipient

NCT ID: NCT03196479 Completed - Clinical trials for Adult Patients Undergoing ERCP

Comparison Between Efficacy of Ketamine and Propofol Mixture With 1:6 Ratio and 1:4 Ratio for Endoscopic Retrograde Procedure Sedation

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

This study aimed to compare the efficacy of ketamine and propofol mixture with 1:6 ratio and 1:4 ratio for endoscopic retrograde procedure